Reimagine regulatory service delivery.


As pharmaceutical regulation continues to diversify for global and local markets and adapts to accommodate increasingly complex pharmaceuticals, many sponsors are renegotiating how they conduct their regulatory workflows. New technologies are emerging to help augment the workloads of overburdened regulatory workers, including artificial intelligence (AI), machine learning (ML), robotic process automation (RPA), natural language processing (NLP), ChatGPT, and more. By leveraging these technologies, sponsors are better positioned to meet their regulatory management goals, which include:
Systemic regulatory augmentation does not aim to make human regulatory workers obsolete, but rather, to assist them in leveraging their expertise and reducing their busy work. By using innovative technology and high-quality data to implement automations, regulatory workers can increase their productivity and focus their efforts in a more targeted fashion. The augmentation breaks down into three tiers:
To establish streamlined automation systems, companies will need to rely on data governance, integrated regulatory information management (RIM) platforms, and regulatory intelligence. For sponsors struggling to navigate regulatory management with their current resources, opting to partner with an experienced regulatory resources organization can help your team mitigate high costs, navigate unplanned regulatory events, and work smarter rather than harder. Furthermore, an outsourcing partner can help your team implement new technologies to ensure better service and high efficiency processes.
Reimagine regulatory service delivery.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.